Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 17
|
pp. 8744–8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Back to article
Figure 3
(3 of 14)
−
100%
+
Figure 3.
The association between CLCN4 expression and cancer pathological grades (stage I, II, III, IV).
(
A
) ACC. (
B
) KIRC. (
C
) LUAD. (
D
) PAAD. (
E
) TGCT. (
F
) THCA.
